Characterization of CD Responders to Vedolizumab

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Crohn's Disease

NCT00783692 ·Status: COMPLETED ·Phase: PHASE3

Synergistic Effect of Vedolizumab and Pentoxifylline

NCT02953275 ·Status: COMPLETED ·Phase: EARLY_PHASE1

A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in Real-World Practice

NCT04890262 ·Status: COMPLETED

A Study of Vedolizumab and Biologic Agents in Participants With Inflammatory Bowel Disease (IBD)

NCT05596422 ·Status: COMPLETED

Value of IUS in Predicting Vedolizumab Efficacy and Assessing Transmural Healing in Early Crohn's Disease: A Multicenter, Prospective Study

NCT07093294 ·Status: RECRUITING

Study of Vedolizumab in Patients With Moderate to Severe Crohn's Disease

NCT01224171 ·Status: COMPLETED ·Phase: PHASE3

Vedolizumab Subcutaneous (SC) Versus Intravenous (IV) in Ulcerative Colitis or Crohn's Disease

NCT02913508 ·Status: WITHDRAWN ·Phase: PHASE2

A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease

NCT06045754 ·Status: RECRUITING ·Phase: PHASE4

A Study in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) Receiving Vedolizumab in Real-World Practice in Switzerland

NCT04989907 ·Status: COMPLETED

Effectiveness of Vedolizumab in CD Patients Naïve to Anti-TNF

NCT02820493 ·Status: WITHDRAWN ·Phase: PHASE4

Effect of Intravenous (IV) Vedolizumab on Mucosal Healing in Crohn's Disease

NCT02425111 ·Status: COMPLETED ·Phase: PHASE3

A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD)

NCT04779320 ·Status: RECRUITING ·Phase: PHASE3

Long Term Safety of Vedolizumab (MLN0002) in Patients With Ulcerative Colitis and Crohn's Disease

NCT00619489 ·Status: COMPLETED ·Phase: PHASE2

Corticosteroids With Vedolizumab in Crohn's Disease

NCT02324699 ·Status: TERMINATED ·Phase: PHASE4

A Study to Assess the Effectiveness and Safety of Treatment With Vedolizumab in Adult Participants With Ulcerative Colitis (UC) or Crohn's Disease (CD) in Real Life

NCT03378388 ·Status: TERMINATED

A Study of Real-World Outcomes of People With Crohn's Disease (CD)

NCT05056441 ·Status: COMPLETED

A Study in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) Receiving Vedolizumab in Real-World Practice in Poland

NCT05384080 ·Status: COMPLETED

Specified Drug-Use Survey on Vedolizumab for IV Infusion 300 mg [Crohn's Disease]

NCT04002180 ·Status: ACTIVE_NOT_RECRUITING

A Study of Vedolizumab in Adults in Real-World Practice

NCT04872491 ·Status: COMPLETED

Comparison of Vedolizumab Treatment to Adalimumab Dose Intensification in Crohn's Disease Patients With Loss of Response or Biomarker Activity to Adalimumab on First Line With Therapeutic Drug Concentration.

NCT06180382 ·Status: RECRUITING ·Phase: PHASE4

Defining Predictors of RT Response to Vedolizumab in IBD

NCT03142321 ·Status: COMPLETED ·Phase: PHASE4

A Study of Vedolizumab in Adult Participants With Moderate to Severe Crohn's Disease

NCT05837897 ·Status: RECRUITING ·Phase: PHASE3

Vedolizumab IV in Pediatric Participants With Ulcerative Colitis (UC) or Crohn's Disease (CD)

NCT03138655 ·Status: COMPLETED ·Phase: PHASE2

Study to Determine Relationship Between Serum Infliximab and Efficacy in Luminal Crohn's Disease Patients

NCT00676988 ·Status: COMPLETED

A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)

NCT06095128 ·Status: RECRUITING ·Phase: PHASE4